SCM
DXCM icon

Sterling Capital Management’s DexCom DXCM Stock Holding History

Sterling Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.71M Sell
84,802
-16,065
-16% -$1.07M 0.1% 185
2026
Q1 		$6.33M Sell
100,867
-39,813
-28% -$2.77M 0.12% 157
2025
Q4 		$9.34M Sell
140,680
-266,400
-65% -$17.2M 0.15% 111
2025
Q3 		$27.4M Buy
407,080
+56,940
+16% +$4.51M 0.4% 54
2025
Q2 		$30.6M Buy
350,140
+93,526
+36% +$7.33M 0.43% 50
2025
Q1 		$17.5M Sell
256,614
-10,018
-4% -$818K 0.27% 65
2024
Q4 		$20.7M Sell
266,632
-18,528
-6% -$1.37M 0.28% 60
2024
Q3 		$19.1M Buy
+285,160
New +$23.4M 0.25% 66
2019
Q3 		$5.36M Buy
143,760
+42,120
+41% +$1.64M 0.05% 240
2019
Q2 		$3.81M Buy
101,640
+31,400
+45% +$987K 0.04% 281
2019
Q1 		$2.09M Sell
70,240
-54,760
-44% -$1.92M 0.02% 395
2018
Q4 		$3.74M Buy
+125,000
New +$3.97M 0.04% 260
2018
Q1 		– Sell
-98,852
Closed -$1.42M – 855
2017
Q4 		$1.42M Hold
98,852
– – 0.01% 499
2017
Q3 		$1.21M Sell
98,852
-69,560
-41% -$1.23M 0.01% 545
2017
Q2 		$3.08M Sell
168,412
-63,852
-27% -$1.18M 0.03% 293
2017
Q1 		$4.92M Buy
232,264
+1,748
+0.8% +$34.1K 0.05% 235
2016
Q4 		$3.44M Sell
230,516
-5,856
-2% -$104K 0.03% 285
2016
Q3 		$5.18M Buy
236,372
+25,436
+12% +$566K 0.05% 233
2016
Q2 		$4.18M Buy
210,936
+25,212
+14% +$429K 0.04% 262
2016
Q1 		$3.15M Buy
185,724
+42,176
+29% +$705K 0.03% 305
2015
Q4 		$2.94M Buy
143,548
+36,804
+34% +$766K 0.03% 308
2015
Q3 		$2.29M Buy
106,744
+21,260
+25% +$474K 0.02% 343
2015
Q2 		$1.71M Buy
85,484
+70,988
+490% +$1.25M 0.02% 324
2015
Q1 		$226K Buy
+14,496
New +$219K ﹤0.01% 829

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Sterling Capital Management's DXCM Position: Q2 2026 in Review

Sterling Capital Management reduced its DexCom (DXCM) stake by 16% in Q2 2026, selling an estimated $1.07M and leaving 84,802 shares worth $5.71M. The position accounts for 0.1% of the portfolio, ranked #185.

Sterling Capital Management first reported a position in DXCM in Q1 2015 and has held it in 24 quarters since. The position peaked at $30.6M in Q2 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Sterling Capital Management held 84,802 shares of DexCom worth $5.71M as of Q2 2026.
  • Sterling Capital Management sold 16,065 DexCom shares in Q2 2026, an estimated $1.07M.
  • DexCom made up 0.1% of Sterling Capital Management's portfolio in Q2 2026, its #185 holding.
  • Sterling Capital Management first reported a position in DexCom in Q1 2015 and has held it in 24 quarters since.
  • Sterling Capital Management's DexCom position peaked at $30.6M in Q2 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.